World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—
Oryzon Genomics in brief
Oryzon Genomics is a listed company in the Biotechnology industry, based in Spain. Its last known market value was $120 M (January 2024); there is no current figure.
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Market cap history
World rank over time
▼ down 4,195 places since 2020
Rank in Spain: #91 (Jan 2020) · #84 (Jan 2021) · #92 (Jan 2022) · #101 (Dec 2022) · #107 (Jul 2023) · #109 (Jan 2024)
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Oryzon Genomics🇪🇸 | $120 M | — | — | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Profile updated:
- Nov 15, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Oryzon Genomics? Verify and update this profile — free
Show Oryzon Genomics's ranking on your website Get the badge
The badge updates itself as the ranking changes.